ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1761

Juvenile Idiopathic Arthritis Genetic Risk Haplotypes: Relevance to Children of African Ancestry

Sabrina George1, Hannah C Ainsworth2, Kaiyu Jiang3, Gilad Barshad4, Adam He4, Edward Rice4, Carl D Langerfeld2, Charles G Danko4 and James N Jarvis3, 1University at Buffalo Jacobs School of Medicine, Buffalo, NY, 2Wake Forest University, Winston-Salem, NC, 3University of Washington School of Medicine, Seattle, WA, 4Cornell University Baker School of Veterinary Medicine, Ithaca, NY

Meeting: ACR Convergence 2024

Keywords: genetics, genomics, Juvenile idiopathic arthritis, Minority Health

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Pediatric Rheumatology – Basic Science Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: – Numerous juvenile idiopathic arthritis (JIA) risk loci have been identified, overwhelmingly from cohorts of children of European ancestry (EA). The extent to which these regions confer risk in individuals of non-European ancestry is unknown, although JIA occurs in children of African ancestry as frequently as in those of European ancestry {Schwartz et al, J Rheum 1997). We posit that the functional mechanism of the true risk-driving variants should generally span ancestries. Thus, identifying the causal variants on risk haplotypes in EA will facilitate assessment of risk in non-European populations, minimizing the effects of linkage disequilibrium.     

Methods: Using published JIA risk regions from EA cohorts (3,939 children with JIA and 14,412 healthy controls), we selected regions containing single nucleotide polymorphisms (SNPs) that met FDR P< 0.05. In these regions, we identified those SNP residing in open chromatin in multiple immune cell types (neutrophils, CD4+ T cells) using ATACseq and regulatory regions identified using H3K4me1 and H3K27ac marks. We further filtered these SNPs for those located in regions of bi-directional transcription initiation characteristic of non-coding regulatory regions detected using dREG to analyze global run-on sequencing (GROseq) data in resting human CD4+ T cells. We examined the allele frequencies of these SNPs in multiple ancestries using NIH Ldlink/Ldhap.

 

Results: We identified 846 SNPs meeting FDR P< 0.05 spanning 24 known JIA risk regions and that were situated within regions of open chromatin in neutrophils or CD4+ T cells.  Of these SNPs, 138 SNPs were within regions of bi-directional transcription initiation characteristic of non-coding regulatory regions. These 138 SNPs are therefore strong causal candidates. We found that 86% of these SNPs could be identified in individuals of African ancestry identified in Ldlink, although there were differences in allele frequency. In individuals of African ancestry, 18 flipped major/minor allele frequency compared to EA and 49 had increased allele frequency of 0.05 in AA. Thus, although the allele frequencies differed across ancestries in some cases, most of our 138 candidate causal SNPs were identified in both EA and AA. 

Conclusion: Plausible causal SNPs situated within known JIA risk loci can be identified in individuals of both African and European ancestry, suggesting that, within these loci, the same genetic mechanisms driving risk are likely to be operating.  Our functional prioritization pipeline of JIA-associated SNPs identified 138 high priority candidate SNPs for investigation across ancestral groups. Coupled with the knowledge of allele frequencies, analyzing a priori functionally-SNPs greatly increases the statistical power to detect associations in other ancestries. Current work is focused on exploring these associations in the UK Biobank data, emphasizing SNPs where allele frequency and sample size provides sufficient statistical power.


Disclosures: S. George: None; H. Ainsworth: None; K. Jiang: None; G. Barshad: None; A. He: None; E. Rice: None; C. Langerfeld: None; C. Danko: None; J. Jarvis: None.

To cite this abstract in AMA style:

George S, Ainsworth H, Jiang K, Barshad G, He A, Rice E, Langerfeld C, Danko C, Jarvis J. Juvenile Idiopathic Arthritis Genetic Risk Haplotypes: Relevance to Children of African Ancestry [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/juvenile-idiopathic-arthritis-genetic-risk-haplotypes-relevance-to-children-of-african-ancestry/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/juvenile-idiopathic-arthritis-genetic-risk-haplotypes-relevance-to-children-of-african-ancestry/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology